# Skylight Investment

> Skylight Investment is a VC fund backing Biotechnology. See 7 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Brookline, United States
- Total investments: 7
- Last investment: Jul 2022
- Lead investor: 14%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/geleichen
- Website: http://skylightinv.com/

Skylight Investment is a VC fund in Brookline focused on Biotechnology and Information Technology. As a newly founded US dollar investment company, Skylight grew out of a well-known Chinese investment company called Taiyou Investment.Taiyou Investment is funded by Mr. Yu longwen, a successful entrepreneur.The second LP of Taiyou is Mr. Yu Minhong, the CEO of New Oriental (NYSE:EDU) The Skylight inherits the plentiful resources that Taiyou has inChina.In addition, The Skylight has a very deep cooperation with Zhen Fund, which is generally accepted as the best angel fund in China.https://angel.co/skylight-investment

## Contacts

5 contacts available for Skylight Investment. Shizune tracks 1 team members at Skylight Investment. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/skylight-investment?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 43% |
| Information Technology | 3 | 43% |
| Medical | 2 | 29% |
| Software | 2 | 29% |
| Therapeutics | 2 | 29% |

22 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 29% |
| Series A | 2 | 29% |
| Angel | 1 | 14% |
| Pre-Seed | 1 | 14% |
| Convertible Note | 1 | 14% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Yubo Ruan | Co-Founder | 0 | https://shizune.co/investors/profile/yubo-ruan |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| B9 | B9 is a fintech which allows underbanked Americans to demonstrate and build their creditworthiness based on their economic behavior. | $2.6M | Seed | Jul 29, 2022 |  |
| Cardea Bio | Cardea is developing a new generation of (bio)technology infrastructure based on proprietary biology-gated transistors. Cardean transistors leverage biocompatible graphene instead of silicon and replace optical signal observations with direct electrical molecular signal analysis. With Cardean transistors, the company and its Innovation Partners cangenerate streaming multi-omics data to measure real-time biological signals. Cardea is now manufacturing chips at scale and partners have started to significantly expand the amount, type, and quality of biological data they capture by building products that Conduct Biolog. | $7.5M | Series A | Sep 17, 2020 |  |
| Butlr | Butlr is an AI people-sensing platform using body heat to detect occupancy, headcount, body posture, and activity, and generate accurate, real-time, and historical spatial insights for healthcare and sustainable buildings. Their sensor technology detects human presence anonymously using low-resolution thermal data and advanced AI and machinelearning. |  | Pre-Seed | Jun 26, 2020 |  |
| Tivic Health | Tivic Health is a bioelectronic therapeutics company. We translate neuroscience into consumer-friendly medical devices, expanding the role of bioelectronic therapies in the healthcare ecosystem.Their first innovation, ClearUP™ Sinus Pain Relief, delivers temporary relief of sinus pain. It’s a small handheld device that’s easy to use, re-usable,and clinically proven. The company received FDA Clearance January 2, 2019 and will be shipping product in September 2019. | $8M | Seed | Jul 23, 2019 |  |
| Valitor | Valitor, Inc. has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacokinetics, target specificity and bioactivity. Their technology platform can be broadly applied to improve the pharmacological properties of many protein drugs that are currently approved or under development. They currentlyhave three development pipelines in the fields of dermatology, ophthalmology, and orthopedics that highlight the capabilities of their novel drug products.​ | $2.5M | Series A | Sep 20, 2018 |  |
| Deuro | Our Mission:Let artificial intelligence penetrate to every industryOur Vision:Short-Term: Build an authoritative, reliable, and trustworthy trading platform to link artificial intelligence services by docking buyers and sellers globally.Mid-Term: Empower growth of Chinese AI industry and contribute to the global development ofartificial intelligence.Long-Term: Create a global artificial intelligence ecosystem which established, owned, and shared by every people |  | Angel | Aug 06, 2018 |  |
| Tivic Health | Tivic Health is a bioelectronic therapeutics company. We translate neuroscience into consumer-friendly medical devices, expanding the role of bioelectronic therapies in the healthcare ecosystem.Their first innovation, ClearUP™ Sinus Pain Relief, delivers temporary relief of sinus pain. It’s a small handheld device that’s easy to use, re-usable,and clinically proven. The company received FDA Clearance January 2, 2019 and will be shipping product in September 2019. | $2M | Convertible Note | Sep 01, 2017 |  |

7 of 7 investments shown.

## Co-investors
- [Astia Angels](https://shizune.co/investors/profile/astia-angels) — VC Fund, 2 deals together
- [Photon Fund](https://shizune.co/investors/profile/photon-fund) — VC Fund, 2 deals together
- [Sierra Angels](https://shizune.co/investors/profile/sierra-angels) — VC Fund, 2 deals together
- [500 Global](https://shizune.co/investors/profile/500-startups) — VC Fund, 1 deal together
- [Agilent Technologies](https://shizune.co/investors/profile/agilent) — VC Fund, 1 deal together
- [AlphaCoin Fund](https://shizune.co/investors/profile/alphacoin-fund) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Skylight Investment invest in?

Skylight Investment invests primarily in Biotechnology, Information Technology and Medical startups, most often at Seed and Series A stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Skylight Investment?

Public channels for Skylight Investment include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Skylight Investment?

The team at Skylight Investment includes Yubo Ruan (Co-Founder). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co